Discovery and Evaluation of 6,7‐Dimethoxy‐1,2,3,4‐Tetrahydroisoquinoline Derivatives as P‐gp Inhibitors to Overcome Multidrug Resistance in Eca109/VCR Cells
ChemMedChem · 14.05.2026 · 21 (9)
DOI: 10.1002/cmdc.202501112 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 30.04.2026. Verfasst von Wen-Jing Lai und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Environmental Engineering, Sichuan University of Science and Engineering, Zigong, China. Hauptthemen laut MEDLINE: Tetrahydroisoquinolines, Drug Resistance, Multiple, Drug Resistance, Neoplasm, ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit nennt 71 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, Natural Science Foundation of China, Postgraduate Teaching Reform Project of the Chongqing Education Commission.
Abstract (Originalsprache)
The efficacy of chemotherapy against malignant tumors is severely limited by multidrug resistance (MDR), of which the overexpression of P‐glycoprotein (P‐gp) is recognized as a key mechanism. Consequently, the development of potent, low‐toxicity P‐gp inhibitors represents a crucial direction in anticancer drug research. Based on our group's prior work on P‐gp inhibitors and supported by molecular docking analysis, 21 novel tetrahydroisoquinoline derivatives were designed and synthesized in this study. Their ability to reverse MDR was assessed in the human esophageal carcinoma multidrug‐resistant cell line Eca109/VCR. The most active compound 21 demonstrated a superior reversal fold (RF = 654) compared to the third‐generation P‐gp inhibitor TQ , as confirmed by colony formation and flow cytometry assays. Mechanistic investigations, including chemosensitization, intracellular fluorescent substrate accumulation, and molecular docking studies, verified that the MDR reversal effect of compound 21 is mediated through P‐gp inhibition. This work provides a new strategic direction for developing tetrahydroisoquinoline‐based sensitizers to overcome tumor drug resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Environmental Engineering, Sichuan University of Science and Engineering, Zigong, China.
- Department of Medicinal Chemistry, Third Military Medical University, Chongqing, China.
ORCID-Profile: Yulong Li, Rong Zeng, Qin Ouyang
Förderung
- Natural Science Foundation of Chongqing Municipality
- Natural Science Foundation of China
- Postgraduate Teaching Reform Project of the Chongqing Education Commission
- Natural Science Foundation of Sichuan Province
- Scientific Research Innovation Team Program of Sichuan University of Science and Engineering
- Key Science and Technology Projects of Zigong City
- Natural Science Foundation of Chongqing
- Sichuan Provincial Natural Science Foundation
Zitieren
APA
Lai, W. J., Guo, C. L., Xia, J. Y., Cao, W. X., Li, H. W., Yu, T., Tian, L., Xie, Y., Li, Y., Zeng, R., & Ouyang, Q. (2026). Discovery and Evaluation of 6,7‐Dimethoxy‐1,2,3,4‐Tetrahydroisoquinoline Derivatives as P‐gp Inhibitors to Overcome Multidrug Resistance in Eca109/VCR Cells. ChemMedChem, 21(9). https://doi.org/10.1002/cmdc.202501112
Vancouver
Lai WJ, Guo CL, Xia JY, Cao WX, Li HW, Yu T, et al. Discovery and Evaluation of 6,7‐Dimethoxy‐1,2,3,4‐Tetrahydroisoquinoline Derivatives as P‐gp Inhibitors to Overcome Multidrug Resistance in Eca109/VCR Cells. ChemMedChem. 2026;21(9). doi:10.1002/cmdc.202501112
BibTeX
@article{Lai2026,
author = {Lai, Wen-Jing and Guo, Chun-Ling and Xia, Jin-Yu and Cao, Wen-Xuan and Li, Hong-Wei and Yu, Tao and Tian, Lan and Xie, Ying and Li, Yulong and Zeng, Rong and Ouyang, Qin},
title = {Discovery and Evaluation of 6,7‐Dimethoxy‐1,2,3,4‐Tetrahydroisoquinoline Derivatives as P‐gp Inhibitors to Overcome Multidrug Resistance in Eca109/VCR Cells},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {9},
doi = {10.1002/cmdc.202501112}
}
EUVIMED